Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-02-15

Clinical Trial Update: An Assessment of Prasugrel on Healthy Adults and Sickle Cell Adults [Phase 1]

View source ↗

Summary

Phase 1 trial assessing prasugrel in healthy adults and adults with sickle cell disease; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prasugrel (Effient) (prasugrel)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Anemia, Sickle Cell | Phase 1 | Status: COMPLETED | Results posted: 2012-02-15